• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Avian flu studies are fit to print, says U.S. biosecurity board

April 4, 2012

National Science Advisory Board for Biosecurity recommends publishing revised studies on mutated H5N1 virus.

After careful examination, the National Science Advisory Board for Biosecurity (NSABB) has recommended publishing two controversial studies of the mutated H5N1 virus.

The U.S. Department of Health and Human Services recently asked the NSABB to evaluate two independent studies: One conducted by Dr. Yoshihiro Kawaoka of the University of Wisconsin-Madison School of Veterinary Medicine and another by Dr. Ron Fouchier in the Netherlands. In its evaluation, the NSABB considered the risks and benefits associated with publishing information that could lead to potential bioterrorism threats. (Click here to read more about the controversy.)

After a two-day deliberation on March 29-30, the NSABB unanimously recommended that Dr. Kawaoka’s revised study should be published in full. The board also recommended (in a 12-to-six decision) publishing the data, methods, and conclusions revealed in the research.

The NSABB says it strongly supports the unrestricted communication of research information unless that information could be misused to pose a risk to public health and safety. Publishing the revised studies still presents dual use concerns, however, so why did the board vote in favor of spreading the word? Here are the NSABB’s stated reasons:

1. The data in the revised studies don’t appear to provide information that would immediately enable misuse of the research in ways that would endanger public health or national security.

Advertisement

2. New evidence has emerged that underscores the fact that understanding specific mutations may improve international surveillance and public health and safety. Global cooperation, critical for pandemic influenza preparedness efforts, is predicated upon the free sharing of information and was a fundamental principle in evaluating these manuscripts.

The NSABB’s recommendations were informed by the newly released U.S. Government Policy for Oversight of Life Sciences Dual Use Research of Concern. This policy applies to federally funded life sciences research and will ensure that dual use concerns are addressed during evaluation of ongoing and future research on H5N1 influenza virus.

As a part of these deliberations, the board emphasized a need for developing processes for responsible communication of research of concern. The NSABB says improving public health and safety will require a sustained global approach to addressing dual use concerns presented by life sciences research while encouraging a robust research enterprise.

The NSABB recommendations will be forwarded to the U.S. government for review and consideration.

Related Content:

Breaking News
Veterinarian kills 2 police officers in Mississippi
Veterinarian kills 2 police officers in Mississippi
FDA conditionally approves Panoquell-CA1 for acute onset of canine pancreatitis
FDA conditionally approves Panoquell-CA1 for acute onset of canine pancreatitis
Veterinarians reflect on Queen Elizabeth’s legacy and love of animals
Veterinarians reflect on Queen Elizabeth’s legacy and love of animals

Advertisement

Latest News

3 Must-reads from Fetch Charlotte 2023

A practical approach to a fever of unknown origin

Bridge Club aims to bring groomers and veterinarians together

ABVS approves full recognition for shelter medicine practice

View More Latest News
Advertisement